Lantheus Holdings, Inc.

ISIN US5165441032

WKN A117UE

Market cap (in EUR)

5,305 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Show more Show less

Healthcare Healthcare Equipment Other Medical Devices United States

Chart

Financials

Key metrics

Market capitalisation, EUR	5,305 m
EPS, EUR	3.58
P/B ratio	4.5
P/E ratio	22.8
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	1,367 m
Net income, EUR	207 m
Profit margin	15.15%

What ETF is Lantheus Holdings, Inc. in?

There are 3 ETFs which contain Lantheus Holdings, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Lantheus Holdings, Inc. is the JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist).

ETF	Weight	Investment focus	Fund size (in m EUR)
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.01%	Equity World Social/Environmental	531
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.01%	Equity North America Social/Environmental	26
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.08%	Equity United States Small Cap	210

Performance

Returns overview

YTD	+42.64%
1 month	+17.04%
3 months	+29.68%
6 months	+67.60%
1 year	+22.64%
3 years	-9.28%
5 years	-
Since inception (MAX)	+1.65%
2025	-34.60%
2024	+54.80%
2023	+19.30%
2022	-

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).